ACC.26 advanced registration ends Feb. 12 – register now!

Andrew P. DeFilippis, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Velakor Biotherapeutics, Inc(MODEST)

View Full Disclosure